Mouse Anti-CXCL6 Recombinant Antibody (CBFYC-2521) (V2LY-0125-LY722)

Jiang, Y., Xi, Y., Li, Y., Zuo, Z., Zeng, C., Fan, J., ... & Guo, Y. (2022). Ethanol promoting the upregulation of CXC Motif Chemokine Ligand 1（ CXCL1） and CXC Motif Chemokine Ligand 6（ CXCL6） in models of early alcoholic liver disease. Bioengineered, 13(3), 4688-4701.

Wang, S. Z., Zhang, Y. L., & Shi, H. B. (2021). Potential Repressive Impact of microRNA-20a on Renal Tubular Damage in Diabetic Kidney Disease by Targeting CXC Motif Chemokine Ligand 6. Archives of Medical Research, 52(1), 58-68.

Wang, X., Dai, Y., Zhang, X., Pan, K., Deng, Y., Wang, J., & Xu, T. (2021). CXCL6 regulates cell permeability, proliferation, and apoptosis after ischemia–reperfusion injury by modulating Sirt3 expression via AKT/FOXO3a activation. Cancer Biology & Therapy, 22(1), 30-39.

Zheng, S., Shen, T., Liu, Q., Liu, T., Tuerxun, A., Zhang, Q., ... & Lu, X. (2021). CXCL6 fuels the growth and metastases of esophageal squamous cell carcinoma cells both in vitro and in vivo through upregulation of PD‐L1 via activation of STAT3 pathway. Journal of Cellular Physiology, 236(7), 5373-5386.

Sun, C., Li, G., & Liu, M. (2020). A novel circular RNA, circ_0005394, predicts unfavorable prognosis and contributes to hepatocellular carcinoma progression by regulating miR-507/E2F3 and miR-515-5p/CXCL6 signaling pathways. OncoTargets and therapy, 13, 6171.

Liu, G., An, L., Zhang, H., Du, P., & Sheng, Y. (2019). Activation of CXCL6/CXCR1/2 axis promotes the growth and metastasis of osteosarcoma cells in vitro and in vivo. Frontiers in pharmacology, 10, 307.

Yamamoto, Y., Kuroda, K., Sera, T., Sugimoto, A., Kushiyama, S., Nishimura, S., ... & Yashiro, M. (2019). The clinicopathological significance of the CXCR2 ligands, CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, CXCL7, and CXCL8 in gastric cancer. Anticancer research, 39(12), 6645-6652.

Shen, W., Xie, X. Y., Liu, M. R., & Wang, L. L. (2019). MicroRNA-101-5p inhibits the growth and metastasis of cervical cancer cell by inhibiting CXCL6. Eur Rev Med Pharmacol Sci, 23(5), 1957-1968.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols